Can Dr Reddy’s shrug off Revlimid’s patent expiry?
DRL also faces headwinds because of increasing competitive intensity in the generic market and exchange rate volatility.
Dr. Reddy’s Faces GST Tax Demand, Evaluates Appeal
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Dr. Reddy's Laboratories falls Friday, underperforms market
Dr. Reddy's Laboratories Ltd. 500124 shares slid 1.27% to 1,354.20 Indian rupees Friday, on what proved to be an all-around ...
Geode Capital Management LLC Buys 6,920 Shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY)
Geode Capital Management LLC increased its position in Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 109.3% ...
Dr Reddys Share Price Live Updates: Dr. Reddys stock ends at Rs 1371.6
Discover the Dr Reddys Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...